LCTX
Lineage Cell Therapeutics Inc
0.9303$
+2.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.6% | +0.0% | -18.9% | -0.7% | +7.1% | +8.6% | +4.3% | +4.1% | +4.5% | +1.1% | -0.5% | – | |
| – | -16.5% | +9.7% | +9.1% | +4.8% | -1.1% | -7.5% | +1.7% | -3.2% | -8.4% | +6.7% | +36.6% | – | |
| – | – | – | – | – | – | – | – | – | – | -2,651.8% | – | – | |
| – | -34.5% | -58.2% | +31.6% | +124.0% | +225.9% | -73.4% | -85.6% | -14.3% | +825.0% | -50.5% | +0.0% | – | |
| – | +359.1% | -100.4% | +23,039.5% | – | -32.2% | -27.8% | -100.7% | -14.3% | +127,683.3% | -84.8% | – | – | |
| – | – | -88.4% | -100.0% | – | -100.0% | – | -100.0% | – | – | +3,900.0% | -100.0% | – | |
| – | – | – | – | – | +7.7% | +0.0% | +0.0% | +14.3% | -6.3% | -6.7% | -35.7% | – | |
| – | -101.6% | – | -99.3% | -102.9% | – | -76.8% | -106.1% | – | +1,011.2% | -72.7% | -19.7% | – | |
| – | – | +103.7% | -271.6% | – | – | -89.0% | -380.0% | – | – | -1,498.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.